Belmont, CA, United States of America

John S Abrams


Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 81(Granted Patents)


Company Filing History:


Years Active: 1991-2002

Loading Chart...
7 patents (USPTO):Explore Patents

Title: John S. Abrams: Innovator in Monoclonal Antibody Development

Introduction

John S. Abrams is a notable inventor based in Belmont, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of humanized monoclonal antibodies. With a total of 7 patents to his name, Abrams has established himself as a key figure in medical research and innovation.

Latest Patents

Among his latest patents is the design, cloning, and expression of humanized monoclonal antibodies against human interleukin-5. This patent describes a monoclonal antibody that specifically binds to human interleukin-5. It also includes a hybridoma that produces the monoclonal antibody, complementary DNAs encoding the heavy and light chain variable regions of the antibody, and humanized monoclonal antibodies. Additionally, the patent covers pharmaceutical compositions that comprise the monoclonal antibody or anti-idiotypic antibodies directed against it, as well as binding fragments and single-chain binding proteins derived from the antibody.

Career Highlights

John S. Abrams has been associated with Schering Corporation, where he has played a pivotal role in advancing research in monoclonal antibodies. His work has contributed to the understanding and treatment of various medical conditions, showcasing his commitment to innovation in the healthcare sector.

Collaborations

Abrams has collaborated with notable colleagues such as Frank D. Lee and Isabelle Chretien. Their combined expertise has further enhanced the research and development efforts in the field of monoclonal antibodies.

Conclusion

John S. Abrams is a distinguished inventor whose work in monoclonal antibody development has had a profound impact on biotechnology. His innovative patents and collaborations continue to shape the future of medical research and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…